for medicinal products containing the active ingredient fremanezumab (ATC code: N02CD03)

Tender Notice

Tender Detail
for medicinal products containing the active ingredient fremanezumab (ATC code: N02CD03)
Tendering Authority
Tender Category
Other
Publish Date
07 Feb 2026
Deadline
31 Mar 2026
Country
Germany
TenderNews Ref. No.
2961517260207-0
Document Fees
Refer Document.
EMD
Refer Document.
Tender Value
Refer Document.
« Previous Tender      Next Tender »

Some of Our Valuable Clients